Our promise to you:
Guaranteed product quality, expert customer support.
24x7 CUSTOMER SERVICE
CONTACT US TO ORDER
Creative Biogene is committed to providing high quality products and services to help scientists around the world find solutions in biological research and drug discovery.
Adeno-associated virus (AAV) has become a popular viral tool for research and clinical applications.
Adeno-associated virus (AAV) belongs to the family of parvoviridae, the viral particles have no envelope, and the structure is an ortho icosahedron with a diameter of about 20 nm.
Cardiovascular disease is a major cause of mortality affecting human beings. In recent years, gene therapy has emerged as a promising approach for treating and curing damaged cardiovascular tissues, capable of restoring the heart from a nonfunctional state to a normal state.
Adenovirus was originally used as a vector for gene therapy. In recent years, with the development of the next-generation vectors with increased safety and high immunogenicity to transgene products, its utility as a vaccine vector has continued to increase.
On April 9, 2025, a groundbreaking study published in Cell introduced a novel delivery technology called ENVLPE (Engineered Nucleocytosolic Vehicles for Loading of Programmable Editors), developed by a team of scientists from the Helmholtz Munich Center and the Technical University of Munich.
Copyright © 2026 Creative Biogene. All rights reserved.